Drug intelligence / Profile preview

Lactogyn (Vésale Pharma)

Development stage: Unknown
Lead developer: Ceres Pharma
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Lactogyn is an oral probiotic dietary supplement developed by Vesale Pharma (also known as Vesale Pharmaceutica) specifically for women's intimate health. The formulation contains a combination of three Lactobacillus strains—*Lactobacillus crispatus* (LMG S-29995), *Lactobacillus brevis*, and *Lactobacillus acidophilus*—along with Vitamin C. It utilizes the proprietary Intelicaps® encapsulation technology to deliver 5.4 billion colony-forming units (CFUs) per capsule. The product is designed to restore and maintain healthy vaginal flora, thereby reducing the recurrence of bacterial vaginosis. It has been evaluated in a Phase 2 clinical trial (NCT03601429) for the prevention of recurrent bacterial vaginosis in women and is marketed in over 30 countries as a nutraceutical for fertile, pregnant, and menopausal women.

Brand names: LactogynLactogyn Bloom
Other names: Fémina

Beyond the preview

Go deeper on Lactogyn (Vésale Pharma).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lactogyn (Vésale Pharma).

Explore the full profile